Purpose. Based on world-wide evaluation, the direct agglutination test (DAT) is now generally acknowledged as one of the leading diagnostics for visceral leishmaniasis (VL). To enhance more routine and mass application, but simultaneously ensure safety to both user and environment, further improvements need to be introduced.
INTRODUCTION
In either its liquid or freeze-dried form, the direct agglutination test (DAT) has evidenced an appropriate reliability and stability for the detection of visceral leishmaniasis (VL) sero-postives both at field and laboratory levels [1] [2] [3] . Notwithstanding the high stability reported irrespective of whether it is achieved by fixation in formaldehyde or by freeze-drying, execution of the test nonetheless requires prior treatment of test serum with b-mercaptoethanol (b-ME) [3, 4] . Due to the modest set-up of laboratories and lack of protective facilities in countries such as Sudan and elsewhere, technicians designated for daily DAT execution and mass screening in the field are continuously running the risk of inhaling b-ME and formaldehyde for extended periods of time. Also, because of the lack of facilities and expertise to detoxify or neutralize unutilized portions and byproducts, quantities of these two pollutants unavoidably find their way into the external environment.
In addition to their toxic effect, both b-ME and formaldehyde have very offensive odours, requiring the availability of a fume chamber; therefore, rendering routine and widescale application highly problematic in hospitals with less facilities. Notwithstanding the various harmful effects reported for these two chemicals, no concrete information on their cumulative effects in the long-term for humans or the environment has been given [5] [6] [7] . Both compounds can seriously affect the respiratory and central nervous systems, among other body systems. Formaldehyde in particular is considered as a potent sensitizer and human carcinogen [5] . Since it has a relatively long half-life, formaldehyde spillage can also result in longer-lasting toxicity to aquatic life. Its metabolite formate can cause renal failure.
Although not listed as a carcinogen, even after prolonged exposure, b-ME can seriously damage the eyes, lungs, liver and kidneys [8] . This reducing agent is also reported to be highly toxic for aquatic micro-organisms [9] .
In spite of the undoubted risks reported for humans and the environment, both compounds are indispensible in the production of reliable DAT antigen. b-ME has its merit over other cleaving agents by being cheaper and less demanding as regards storage and use [3, 4, 10, 11] . In order to achieve accurate test readings and the required antigen stability, proper staining and preservation of the promastigotes after b-ME treatment is essential. Similar to other protozoan parasites, successful staining of the antigen requires prior use of a suitable fixative [11, 12] . In our 17 years of experience with DAT production in Sudan, formaldehyde evidenced excellent properties, of which the binding of Coomassie Brilliant Blue (CBB) to the Leishmania donovani promastigote surface membrane is of crucial importance.
The objective in this study was to reduce, or wherever possible totally exclude, the use of formaldehyde and b-ME in both antigen processing and test execution. However, since both compounds are indispensible for the production of a valid test, we have concentrated our efforts on excluding their use in the test procedure. Performance of the liquid DAT (LQ-DAT) version improved in this manner to meet with the requirements for human and environment protection was evaluated for the detection of VL sero-positives against the currently used equivalent, wherein both pollutants are integrated.
METHODS

Current antigen processing procedure
As reported in previous studies, a strain of L. donovani from the Gedaref area (eastern Sudan) isolated from a VL patient from bone-marrow and continuously maintained by subculturing every 7-8 days in Liver Infusion Tryptose (LIT)-hemin medium was used for processing of the antigen [13] . Mass culture of the promastigotes was initiated in LIT medium without the addition of hemin (Oxoid), but with supplementation with FCS [10 % (vol/vol)] (Biowest), penicillin (100 IU) and streptomycin (100 µg ml À1 ), with harvesting 7 days later. Following treatment with b-ME (Sigma) and fixation in 2.0 % (wt/vol) formaldehyde/Locke's solution overnight, the antigen was stained with CBB (Sigma) and re-suspended in citrate-saline (0.9 % wt/vol sodium chloride, 1.0 % wt/vol sodium citrate tribasic dihydrate) containing 1.2 % (wt/vol) formaldehyde. After undergoing routine quality-control procedures employing VL and non-VL standard sera, the finished antigen suspension was stored at 4 C.
Improved antigen processing procedure
In contrast to the procedure in current use mentioned above, following b-ME treatment, the promastigote suspension was fixed in Locke's solution containing 3.0 % (wt/vol) formaldehyde (instead of 2.0 %) for 18 h at 4 C. The fixed promastigote suspension was washed twice by centrifugation in citrate-saline. No significant alteration in the promastigote morphology was observed at this formaldehyde concentration. After washing by centrifugation, the antigen pellet was re-suspended in the same medium to which 0.02 % (wt/vol) CBB was added. The bottle containing the promastigote and CBB suspension was placed on a magnetic stirrer and rotated at moderate speed for 2 h, followed by incubation overnight at 4 C. The stained promastigote antigen suspension was then centrifuged to remove the unbound CBB, washed twice in citrate-saline, and thereafter re-suspended in the same medium supplemented with formaldehyde (1.2 % wt/vol) for 18 h at 4 C. The antigen/ fixative mixture was centrifuged and re-suspended for a second time in citrate-saline for a similar period of 18 h. Following washing twice in citrate-saline, the fixed and stained antigen suspension was finally re-suspended in citrate-saline medium either with or without the addition of formaldehyde (1.2 % wt/vol) for comparison. To overcome possible microbial contamination, a portion of the finished processed antigen was supplemented with sodium dichloroisocyanurate (chlorine) (NSF) at a concentration (0.05 % wt/ vol) below that recommended by the World Health Organization (WHO) for drinking water (0.2-1.0 % wt/vol). Concentrations similar to or higher than those mentioned latterly resulted in partial or complete antigen bleaching. Both antigen suspensions (with or without chlorine treatment) were stored at 4 C until needed.
Improved DAT execution procedure As in the DAT procedure in current use, reported earlier, 0.2 % (wt/vol) gelatin in normal saline was used as a serum diluent after heating for up to +80 C to ensure complete solubility [4, 13] . To reduce non-specific agglutination, the serum gelatin diluent, after cooling at room temperature, was supplemented with either b-ME (0.8 % vol/vol) or urea (0.3 % wt/vol) for comparison. Twofold serial dilutions of the test serum sample were then made in V-shaped microtitre-plate wells (Greiner) starting from well no. 2 with 50 µl of serum diluted 1 : 100 for the VL and 1 : 10 for the non-VL serum samples. Well no. 1 was used as a negative control, wherein only 50 µl gelatin diluent was added. A 50 µl aliquot of the antigen processed according to the current or the improved procedure was then transferred to each well after gentle shaking of the flask containing the antigen. The plate was carefully shaken by hand on a level surface for half a minute, covered and left for 18 h at room temperature (25-30 C). The test was read visually against a white background. The end-point was estimated by localizing a clear sharp-edged blue spot identical to the one observed in the control well. A provisional positive or negative result can be determined within the first 2 h of test incubation.
As reported in previous studies, a titre of 1 : 3200 was considered suggestive of VL [2, 4] . Sera were tested through a full range of dilutions, and titres were expressed as the number of the twofold serial dilution starting from 1 : 100 (dilution 1) up to 1 : 13107200 (dilution 18) or 1 : 10 (dilution 1) up to 1 : 1280 (dilution 8), respectively, for the VL and non-VL sera, to determine the end-point of the agglutination reaction.
Serum samples
All of the serum samples used in this study were from our serum bank at the Laboratory of Biomedical Research, Ahfad University for Women, collected during the period 2005-2017, either through routine VL diagnosis of suspected cases referred to our laboratory from across the country or from field studies on VL conducted in the eastern state of Sudan with the required patient's consent and ethical approval from our Ahfad University for Women, as well as from the Federal Ministry of Health in Khartoum (Sudan) [13, 14] . All collected serum samples remained anonymous. In this study, 96 were included; 50 were from confirmed cases of VL, and 46 from healthy individuals and patients with diseases other than VL.
Study design
The effect of formaldehyde on the agglutinating antibody levels was assessed both in VL (4) and non-VL (4) sera by adding DAT antigen suspension free of this fixative. The serum sample was diluted 1 : 100 (VL) or 1 : 10 (non-VL) in gelatin diluent to which the fixative was added at different concentrations, followed by incubation at laboratory temperature (25 C) for 1 h. To assess the effect of b-ME on the test outcome, the DAT was executed in VL (10) and non-VL (10) sera diluted 1 : 100 (for both VL and non-VL) in a gelatin diluent containing b-ME at a standard concentration of 0.8 % (vol/vol); a control test free of this cleaving agent was carried out simultaneously for comparison. To ascertain whether urea, generally known as being less toxic and less offensive in odour than b-ME, has the potential to sufficiently reduce non-specific reactions in DAT, 46 VL and 20 non-VL sera were assessed. The effect of excluding both formaldehyde and b-ME, respectively, as a preservative and a reducing agent, on DAT performance was evaluated in 50 VL and 46 non-VL sera. Being almost non-toxic at the concentration used here (0.05 % wt/vol) in comparison with formaldehyde, sodium dichloroisocyanurate (chlorine) was evaluated as an alternative antimicrobial for antigen preservation at 4 C for at least 6 months.
Data analysis
To evaluate the effect of b-ME on DAT outcome, the Wilcoxon sign-ranked test was applied between sera diluted either with b-ME or urea. This is a non-parametric freedistribution test for two paired samples whose data should be measured at least at the ordinal level. In order to test the effect of excluding formaldehyde and b-ME, respectively, as preservative or reducing agent, as well as incorporating urea in the DAT procedure, Friedman ANOVA (Fr) in association with the Kendall Concordance coefficient (W) was applied. These two non-parametric tests require similar user input, Friedman ANOVA (Fr) is a non-parametric alternative to one-way repeated measures of variance and the Kendall Concordance coefficient (W) expresses the relationship between multiple cases (0, without agreement, and 1, maximal agreement). In all tests the titration data were transformed logarithmically and applied at a 5 % confidence interval using Statistica 7.1 software (Stat Soft, Tulsa).
RESULTS
At the concentration currently used for antigen preservation (1.2 % wt/vol), the negative effect of formaldehyde on antibody levels, most likely due to the denaturing of serum proteins, was evident both in the VL and non-VL samples (Table 1) . A difference of two steps serial dilution or more in DAT titre reading is commonly acknowledged as significant. Exclusion of formaldehyde as the antigen preservative Table 1 . Effect of formaldehyde on titre readings of sera from subjects with (VL) or without VL (non-VL) applying the current DAT procedure without formaldehyde incorporation as the antigen preservative seems, therefore, advantageous for enhancing DAT sensitivity to detect VL sero-postives. This was achieved by both increasing the concentration of formaldehyde to 3 % (wt/ vol) for fixation of the promastigotes after b-ME cleaving action and by repeating their exposure to the fixative for another 18 h session after CBB staining. Our approach proved to be adequate in maintaining antigen reactivity without further incorporation of this fixative in the suspension medium. Unlike formaldehyde, b-ME incorporation in DAT procedures resulted in a noticeable elevation of specific antibody levels in the VL sera combined with a comparable reduction in those of their non-specific equivalents in the non-VL (Table 2 ).
With the concentration [0.3 % (wt/vol)] considered as optimal in the current procedures, urea proved equally efficient as b-ME in maintaining test sensitivity for the detection of VL sero-positives (P<0.001; T=18.5). Also, as with b-ME, a comparable reduction in non-specific antibody levels was successfully achieved by incorporating urea in the procedures currently followed for DAT execution. This has further justified our expectation that urea can efficiently replace b-ME for VL specific detection (P=0.646; T=23.0) ( Table 3 ).
The stability of the antigen processed in this way without formaldehyde as a preservative was additionally secured by supplementation with sodium dichloroisocyanurate (chlorine) at a concentration significantly lower than that recommended by the WHO for drinking water. In neither the visual nor the microscopic examination conducted during storage for 6 months or longer at 4 C did we observe flocculation, microbial growth or changes in the promastigote morphology (results not shown). Unexpectedly, during this period also, was the absence of all abnormalities mentioned above in the unpreserved controls. Both chlorine-preserved and unpreserved antigen suspensions consistently scored comparable titres against the standard VL and non-VL sera (results not shown).
By excluding formaldehyde from the antigen suspension, circumventing a significant reduction in test serum antibody level, b-ME incorporation in DAT procedures rendered of minor or no effect on the test outcome. Compared with results obtained with the current procedure (involving formaldehyde and b-ME), the improved procedure (formaldehyde-and b-ME-free) evidenced comparable reliability for the discrimination between the VL and non-VL conditions (VL -Fr=52.39, W=0.70, P<0.001; and non-VLFr=65.97, W=0.83, P<0.001). A more noticeable reduction in non-specific agglutination was further achieved by integrating urea in the improved execution procedures ( Table 4) .
DISCUSSION
Besides the diagnostic reliability and stability under adverse conditions and on the grounds of being less demanding in terms of expertise and facilities required in comparison with its WHO equivalent reference freeze-dried DAT and rapid rK39 strip tests, the LQ-DAT can most likely be classified as the test of choice for the detection of VL sero-positives in East Africa [15] [16] [17] . To pave the way for safe routine use and periodic mass screening, the risk of exposure to the two pollutants involved in DAT antigen processing and test execution, namely formaldehyde and b-ME, should wherever possible either be drastically reduced or be completely avoided.
b-ME is used in antigen processing for cleaving promastigote surface native proteins to expose the target L. donovani epitope(s), as well as in test execution to unfold the IgG or IgM antibody molecules involved, revealing by so doing the corresponding and highly binding Fab fragment(s). Although b-ME substitution by proteolytic enzymes such as trypsin for antigen processing has proved successful, the strict conditions required for the storage and use of the latter are considered problematic in modestly equipped laboratories such as ours [18] . Alternative handling steps taken to replace b-ME through repeated washing of promastigotes in Locke's solution or low concentrations of mild detergents, Table 2 . Effect of b-ME on DAT outcome in sera from subjects with (VL) or without (non-VL) VL using formaldehyde-preserved antigens of L. donovani
Clinical condition
No. of sera Titre readings using gelatin serum diluent:
With b-ME* Without b-ME such as sodium dodecyl sulfate, resulted in spontaneous clumping or lysis of promastigotes (unpublished study). In our experience, production of valid DAT antigen batches depends entirely on achieving optimal cleavage of the protein molecules or those of their conjugated forms on the promastigote surface membrane. Even though essential at this phase of test production, b-ME use can still be drastically reduced through processing the antigen in large quantities, thereby minimizing both the risk of repeated exposure to b-ME, as well as variation in the performance of antigen lots produced on different occasions.
Exclusion of b-ME in the test execution, however, proved successful, as shown in this study by applying the improved procedure without the use of formaldehyde as an antigen preservative (VL -Fr=52.39, W=0.70, P<0.001; and non-VLFr=65.97, W=0.83, P<0.001). By taking such an approach, we have succeeded in maintaining the actual anti-L. donovani antibody level, which otherwise could have been reduced when applying the current procedure involving formaldehyde ( Table 4 ). The combined exclusion of formaldehyde as an antigen preservative and incorporation of urea as a reducing agent in the serum diluent resulted in a clearer distinction between the VL sero-positives and VL sero-negatives (Table 4) . Although b-ME and urea exert different effects on antibodies, they both nonetheless reduce the stability of native protein molecules by disrupting the hydrogen-bonding network. This is expected to result in further degradation of the antibody molecules involved, allowing, in turn, for their specific binding with the previously exposed L. donovani epitope.
Formaldehyde is used for both conserving the status of L. donovani epitopes previously exposed by b-ME cleavage action, as well as for prolonging the antigen shelf-life. As has been reported with trypomastigotes of Trypanosoma brucei gambiense, promastigotes of L. donovani showed good affinity to CBB after fixation with formaldehyde [11, 12] . Even by increasing the concentration of this fixative to 3 %, both the colour intensity and percentage of the promastigotes that had picked up the stain remained comparable (80-90 %) to those observed with the currently used procedure for antigen processing [15, 16] .
In this study, we substituted formaldehyde with chlorine to overcome possible microbial contamination, deterioration in morphology of the promastigotes, or interference in the agglutination reaction through non-specific binding with Non-VL Current (with b-ME) invading micro-organisms. Most probably because of the well-conserved status of the antigen, the absence of protein and carbohydrate nutrients in antigen suspension medium and the low storage temperature (4 C) chosen, multiplication of the invading micro-organisms was completely inhibited or so much reduced that even in the control (chlorineÀ) unpreserved antigen aliquots no macroscopic or microscopic abnormalities were observed. This was further supported by the matching titres obtained for this unpreserved antigen with those of the preserved antigen, using standard VL and non-VL sera.
Based on the data presented in Table 4 , one can conclude that by incorporating urea in the improved procedures (b-ME-free), higher DAT specificity can be attained, indicative that an additional step should be included for confirming or excluding VL sero-positivity in those who scored marginal titres (1 : 400-1 : 3200) in the initial testing. At the concentration (0.3 % wt/vol) used here, which is far below that applied for agricultural purposes, no risk, or only a minor risk, of toxicity due to ammonia emission is expected for either the test user or the environment. In addition, fortunately, unlike for formaldehyde or b-ME, urea is not retained for long in the human or animal body and if accidently ingested in small quantities is readily excreted in urine; healthy individuals pass +25 g per day.
We conclude that by introducing the modifications mentioned, we have succeeded to a reasonable degree in increasing the DAT potential for more routine sero-diagnosis and surveillance of possible VL infection. Added to efforts previously undertaken to reduce costs through local production, use autochthonous L. donovani strains to increase sensitivity, and maintain the stability of the antigen for longer periods under adverse high temperatures, we believe the DAT can now more effectively contribute to the control of VL in East Africa [14] [15] [16] [17] 19] . Our only remaining challenge is the shortening of the current incubation period (2 h) to allow for faster qualitative test reading [4] .
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